{"title":"重症监护中的心血管COVID-19患者:系统综述","authors":"Barbara Mayumi Sansana Lee, Winnie da Silva Alves","doi":"10.56242/globalhealth;2022;2;8;10-15","DOIUrl":null,"url":null,"abstract":"OBJECTIVE: Analyse in the literature, the prevalence of cardiovascular diseases (CVD) and the development of cardiac or vascular dysfunctions, in individuals hospitalized in intensive care units (ICU), due to Covid-19. METHODS: Integrative literature review, carried out in the databases: BVS: BDENF and LILACS; PuBMED: MEDLINE; Web of Science and CINAHL. Inclusion criteria, full-text articles, in Portuguese, English or Spanish, published from 2019 onwards. RESULTS: Six articles were selected, and three central themes listed: patients with previous CVD; patients who developed heart or vascular diseases during hospitalization; and patients who presented alterations in biomarkers of cardiac injury and fibrin degradation. A prevalence of CVD between 0 and 29% of the studies was observed, as coronary diseases, arrhythmias, valvular and ventricular dysfunctions, and the incidence of CVD between 2.6 and 59%, presenting electrical, functional, structural alterations and cardiogenic shock. CONCLUSION: An important percentage of patients with Covid-19, admitted to the ICU, who had previous CVD and who developed CVD were identified. However, until the end of this study, there weren’t studies in which 100% of the sample had previous CVD, which would be important for understanding the possible impairments under it. Even as, research that specified the types of involvement developed, named only as “cardiac injuries” or biomarkers increased. As limitations of this study, we emphasize that new research was carried out after its conclusion, which will certainly add better knowledge. This way, the concern about the severity in which Covid-19 can affect people with previous CVD and its cardiovascular manifestations remains.","PeriodicalId":285800,"journal":{"name":"Brazilian Journal of Global Health","volume":"42 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"PACIENTES CARDIOVASCULARES COM COVID-19 EM TERAPIA INTENSIVA: UMA REVISÃO SISTEMÁTICA\",\"authors\":\"Barbara Mayumi Sansana Lee, Winnie da Silva Alves\",\"doi\":\"10.56242/globalhealth;2022;2;8;10-15\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"OBJECTIVE: Analyse in the literature, the prevalence of cardiovascular diseases (CVD) and the development of cardiac or vascular dysfunctions, in individuals hospitalized in intensive care units (ICU), due to Covid-19. METHODS: Integrative literature review, carried out in the databases: BVS: BDENF and LILACS; PuBMED: MEDLINE; Web of Science and CINAHL. Inclusion criteria, full-text articles, in Portuguese, English or Spanish, published from 2019 onwards. RESULTS: Six articles were selected, and three central themes listed: patients with previous CVD; patients who developed heart or vascular diseases during hospitalization; and patients who presented alterations in biomarkers of cardiac injury and fibrin degradation. A prevalence of CVD between 0 and 29% of the studies was observed, as coronary diseases, arrhythmias, valvular and ventricular dysfunctions, and the incidence of CVD between 2.6 and 59%, presenting electrical, functional, structural alterations and cardiogenic shock. CONCLUSION: An important percentage of patients with Covid-19, admitted to the ICU, who had previous CVD and who developed CVD were identified. However, until the end of this study, there weren’t studies in which 100% of the sample had previous CVD, which would be important for understanding the possible impairments under it. Even as, research that specified the types of involvement developed, named only as “cardiac injuries” or biomarkers increased. As limitations of this study, we emphasize that new research was carried out after its conclusion, which will certainly add better knowledge. This way, the concern about the severity in which Covid-19 can affect people with previous CVD and its cardiovascular manifestations remains.\",\"PeriodicalId\":285800,\"journal\":{\"name\":\"Brazilian Journal of Global Health\",\"volume\":\"42 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-08-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Brazilian Journal of Global Health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.56242/globalhealth;2022;2;8;10-15\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brazilian Journal of Global Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.56242/globalhealth;2022;2;8;10-15","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
PACIENTES CARDIOVASCULARES COM COVID-19 EM TERAPIA INTENSIVA: UMA REVISÃO SISTEMÁTICA
OBJECTIVE: Analyse in the literature, the prevalence of cardiovascular diseases (CVD) and the development of cardiac or vascular dysfunctions, in individuals hospitalized in intensive care units (ICU), due to Covid-19. METHODS: Integrative literature review, carried out in the databases: BVS: BDENF and LILACS; PuBMED: MEDLINE; Web of Science and CINAHL. Inclusion criteria, full-text articles, in Portuguese, English or Spanish, published from 2019 onwards. RESULTS: Six articles were selected, and three central themes listed: patients with previous CVD; patients who developed heart or vascular diseases during hospitalization; and patients who presented alterations in biomarkers of cardiac injury and fibrin degradation. A prevalence of CVD between 0 and 29% of the studies was observed, as coronary diseases, arrhythmias, valvular and ventricular dysfunctions, and the incidence of CVD between 2.6 and 59%, presenting electrical, functional, structural alterations and cardiogenic shock. CONCLUSION: An important percentage of patients with Covid-19, admitted to the ICU, who had previous CVD and who developed CVD were identified. However, until the end of this study, there weren’t studies in which 100% of the sample had previous CVD, which would be important for understanding the possible impairments under it. Even as, research that specified the types of involvement developed, named only as “cardiac injuries” or biomarkers increased. As limitations of this study, we emphasize that new research was carried out after its conclusion, which will certainly add better knowledge. This way, the concern about the severity in which Covid-19 can affect people with previous CVD and its cardiovascular manifestations remains.